Tools chosen: kalshi_direct kalshi_related polymarket_related claude_news gdelt_news claude_news wikipedia code_execution

Sub-questions (Fermi decomposition)

Planner reasoning

This is a compound question: Anthropic must (a) complete a US IPO before Jan 1, 2028, and (b) have Goldman Sachs specifically as lead-left bookrunner. Base rates for mega-cap tech IPO lead-left roles (Morgan Stanley vs Goldman vs JPM) and any reported bank-selection news are the key drivers, anchored on the Kalshi price for the whole series.

# Current state Kalshi currently prices Goldman Sachs at 57% to be lead-left underwriter on Anthropic's IPO (resolves YES if it occurs before 2028). Anthropic has confidentially filed a draft S-1 (June 2026) and is actively conducting pre-IPO investor meetings (CFO-led, as of Aug 2026), with Goldman, Morgan Stanley and JPMorgan Chase all engaged as joint bookrunners — but as of the latest reporting (late Aug 2026), the specific "lead-left" designation has NOT been publicly confirmed by any bank or company official. # Timeline of key events - 2026-06-01: Anthropic confidentially files draft S-1 with SEC, optioning a public listing pending market conditions (pymnts.com — confirmed filing, timing uncertain). - 2026-06-03/04: Bloomberg reports Anthropic picked Morgan Stanley and Goldman Sachs as lead IPO banks, JPMorgan also on deal; more banks could join; possible October listing (reported). - 2026-06-10: Fortune reports lead-left slot between Goldman/Morgan Stanley still undecided (reported). - ~2026-06 (completed): Goldman named lead-left on SpaceX's IPO — same-era precedent bolstering Goldman's momentum (confirmed via CNBC). - 2026-06-mid: Polymarket "Lead Bank in Anthropic's IPO" market prices Morgan Stanley 68% / Goldman 26.5% (reported market snapshot, now stale). - 2026-07-15: CNBC reports Anthropic scheduling early investor meetings; GS/MS/JPM all involved; no lead-left confirmation (reported). - 2026-08-13: CFO Krishna Rao personally leading investor education meetings; no exchange/ticker/underwriter officially confirmed (reported, CNBC). - 2026-08-19/21: Reports Anthropic expanding pre-IPO credit facility beyond $10B (SpaceX playbook) and adding Citigroup to top IPO banks (reported). - 2026-08-18/26: Revenue run-rate reaches ~$65B (July), 2028 target $190-200B; valuation speculation up to $2T (reported, multiple outlets). # Event Will Goldman Sachs be confirmed as lead-left underwriter on Anthropic's US IPO before Jan 1, 2028? # Outcomes to forecast Yes / No # Kalshi market anchor GS lead-left ticker (KXANTHROPICLEADLEFT-28JAN01B-GSX): **57% YES**, down 4pts over 7 days, up 7pts over 30 days; thin liquidity (avg 171 contracts/day); 62-day range 28%-88% — market has been volatile, reflecting news-driven repricing as bank roles evolve. # Sub-question answers 1. Kalshi prices GS at 57%. Direct sibling MS/JPM/"no-IPO" tickers in this specific event series were not retrievable (0 matches), but the related "Anthropic vs OpenAI IPO first" market prices Anthropic at 94%, implying market confidence an IPO race is real and imminent, though this doesn't isolate P(IPO by 2028). 2. Yes — confidential S-1 filed June 1, 2026; CFO Krishna Rao running investor meetings since summer 2026; company expanding credit facilities >$10B; reported target of October 2026 listing at up to ~$2T valuation. 3. Yes — Goldman, Morgan Stanley, and JPMorgan all reportedly engaged as joint bookrunners (Bloomberg, June 2026); Citigroup reportedly added Aug 2026; lead-left specifically undecided per Fortune/CNBC as of Aug 2026. Goldman separately secured lead-left on SpaceX's 2026 IPO, a favorable same-cycle precedent. 4. Mixed base rate: Goldman lead-left on Instacart (2023) and SpaceX (2026); Morgan Stanley lead-left on CoreWeave (2025) and Reddit (2024); Arm (2023) split fees evenly with GS as allocation coordinator; Rivian (2021) had MS/GS/JPM joint with MS typically cited first. Goldman wins lead-left roughly 25-40% of marquee tech IPOs historically, with Morgan Stanley its main rival. 5. Anthropic valued ~$965B (May 2026); revenue run-rate ~$65B (July 2026) trending to $100-120B by YE2026, targeting $190-200B by 2028. Large credit facility expansion (>$10B) suggests reduced urgency for IPO cash, but strong momentum toward a 2026-2027 listing given S-1 filing and roadshow activity. 6. Polymarket ran a "Lead Bank in Anthropic's IPO" market (mid-June 2026 snapshot): Morgan Stanley 68% vs Goldman 26.5% — disagrees sharply with Kalshi's current 57%, but that Polymarket data predates Citigroup's addition and further roadshow progress; no live Polymarket market found in current scan (0 matches). # Key facts (high-confidence, factual) 1. [pymnts.com] Confidential S-1 filed June 1, 2026. 2. [Bloomberg] GS, MS, JPM all engaged as joint bookrunners as of June 2026. 3. [Fortune/CNBC] Lead-left undecided as of Aug 2026 reporting. 4. [CNBC] Goldman holds lead-left on SpaceX's 2026 IPO. 5. [CNBC] CFO-led investor meetings underway Aug 2026; no underwriter/exchange/ticker officially confirmed. 6. [moneycontrol] Citigroup reportedly added to top bank roster Aug 2026. 7. [Kalshi] Anthropic-vs-OpenAI-first market prices Anthropic 94% (context, not this market). # Cross-market signals - Kalshi related: Anthropic-first-to-IPO market at 94% (high momentum toward an IPO event, though not this market's exact window). - Polymarket: Stale mid-June snapshot favored Morgan Stanley (68%) over Goldman (26.5%) for lead-left — conflicts with Kalshi's current 57%; likely outdated given subsequent news. - Sportsbook implied: N/A. # Analyst opinions and speculation - Fortune/chicagostarmedia frame this as a genuine "horse race" between GS and MS, with GS's SpaceX lead-left win cited as leverage. - Code-execution two-stage model (base-rate driven) estimates only ~4-5% unconditional probability, but explicitly flags this hinges on a low (5-25%) Stage-1 IPO-by-2028 probability assumption that conflicts with the extensive 2026 reporting (S-1 filed, roadshows active) — that assumption looks too conservative given confirmed process steps. # Directional lean per outcome - **Yes (GS lead-left)**: Supported by GS's SpaceX lead-left precedent, being one of confirmed top-3 banks, and Kalshi's 57% pricing reflecting most recent news. Opposed by Polymarket's stale MS-favoring signal and historical pattern of MS often edging GS on recent big tech deals (CoreWeave, Reddit). - **No**: Supported by lead-left being explicitly unconfirmed, Morgan Stanley's recent lead-left track record, expanding bank syndicate (Citi) diluting clarity, and the possibility IPO doesn't close before Jan 2028 (though this looks low-probability given active S-1/roadshow). # Gaps / unknowns - No confirmed lead-left announcement yet; resolution likely hinges on final prospectus filing (S-1/424B). - Uncertain whether IPO completes before Jan 1, 2028 (probably >70% likely given pace, but not certain). - Polymarket data is stale (~2.5 months old); no current comparable venue found. # Calibration anchors - Kalshi current YES price: **57%** (primary anchor). - Precedent: SpaceX 2026 (GS lead-left), CoreWeave/Reddit (MS lead-left), Instacart (GS lead-left), Rivian/Arm (shared/ambiguous) — GS wins roughly a third to just under half of comparable marquee mandates recently.

1. **Base-rate mismatch unaddressed**: The brief states Goldman wins lead-left on roughly "25-40% of marquee tech IPOs" historically, yet both forecasts land at 54-55% — a large gap from base rate that neither rationale explicitly reconciles beyond citing the SpaceX precedent; this looks like anchoring-induced overconfidence in GS relative to the reference class. 2. **Two-bank framing ignores syndicate breadth**: Both forecasters implicitly treat this as a GS-vs-MS coin flip, but the brief notes JPMorgan and (newly) Citigroup are also joint bookrunners — a four-bank field mechanically caps any single bank's lead-left probability below 50% absent strong differentiating evidence, which neither model incorporates. 3. **Polymarket signal dismissed too quickly**: Both call the Polymarket 68% MS / 26.5% GS snapshot "stale," but no fresher GS-vs-MS-specific data exists to override it — treating it as noise while still landing near a coin flip is inconsistent; if anything it should pull the forecast toward MS more than either did. 4. **Completion-probability treatment diverges without reconciliation**: Forecast 1 explicitly discounts by "~85-90%" IPO-by-2028 probability while Forecast 2 treats IPO completion as near-certain and doesn't multiply it through; despite this methodological difference they converge to nearly identical outputs (54% vs 55%), suggesting the completion-probability adjustment isn't actually doing meaningful work in either model. 5. **No consideration of ambiguous/split resolution**: The brief flags Arm (2023) "split fees evenly" as a precedent where no single lead-left existed — neither forecaster addresses how the market would resolve if Anthropic's IPO similarly lacks a clean single lead-left designation, which could push toward NO by default regardless of GS's relative standing. 6. **Thin/volatile market not suf필ciently discounted**: Given 171 contracts/day and a 62-day range of 28-88%, both forecasts shrink only ~2-3 points from the Kalshi anchor; given the evidence brief's own emphasis on this being "news-driven repricing" on thin liquidity, a wider divergence from 57% (in either direction) would be more defensible than the near-identical trivial haircuts both applied.

49% (50% confidence)

Yes: 49% No: 51%

The Kalshi anchor (57%) is thin, highly volatile (28-88% over 62 days), and merits more shrinkage than either forecaster applied. The critique's strongest points hold: the syndicate is at least four banks (GS, MS, JPM, now Citi), the only venue with a direct GS-vs-MS head-to-head (Polymarket, mid-June) favored Morgan Stanley 68/26.5, MS has won lead-left on the most recent comparable marquee tech deals (CoreWeave, Reddit), and the historical base rate for GS lead-left on marquee tech is roughly 25-40%. Offsetting this, GS is confirmed as one of the two principal lead banks and just won lead-left on SpaceX in the same cycle, which is genuine leverage — so conditional on a clean single lead-left designation the GS-vs-MS contest is close to a coin flip, perhaps slightly under. Multiplying a ~50-53% conditional GS win by ~85-90% probability that the IPO prices with a resolvable lead-left designation before Jan 1, 2028 (plus small risk of an Arm-style ambiguous/split structure resolving NO) lands near 45%; blending that with partial deference to the 57% market print gives ~49%.

Total pipeline time: 181.4s